Ph.D. in Biochemistry, Univ. of Missouri-Columbia.
Thiazolidinediones have been reported to protect against ischemia-reperfusion injury. Their protective actions are considered to be peroxisome proliferator–activated receptor-g (PPAR-g)–dependent; however, it is unclear how PPAR-g activation confers resistance to ischemia-reperfusion injury.